Literature DB >> 3937578

Hypercalcemia associated with increased circulating 1,25 dihydroxyvitamin D in a patient with pulmonary tuberculosis.

N H Bell, J Shary, S Shaw, R T Turner.   

Abstract

Studies are described in a 53-year-old man with far-advanced pulmonary tuberculosis who developed transient increases in circulating 1,25 dihydroxyvitamin D (1,25(OH)2D) and hypercalcemia while on antituberculous treatment. Serial dilution of an extract of the patient's serum obtained while he was hypercalcemic displaced [3H]-1,25(OH)2D3 from chick intestinal receptor in a manner identical to authentic 1,25(OH)2D3. Serum 25-hydroxyvitamin D (25OHD) was suppressed during the abnormal elevation of serum 1,25(OH)2D. It is concluded that tuberculosis is another chronic granulomatous disease in which hypercalcemia may result from abnormal metabolism of vitamin D.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3937578     DOI： 10.1007/bf02554911

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


  25 in total

1.  Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D.

Authors:  G L Barbour; J W Coburn; E Slatopolsky; A W Norman; R L Horst
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

2.  Hypercalcemia in disseminated candidiasis.

Authors:  H M Kantarjian; M F Saad; E H Estey; R V Sellin; N A Samaan
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

3.  Evidence for abnormal regulation of circulating 1 alpha, 25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism.

Authors:  S Epstein; P H Stern; N H Bell; I Dowdeswell; R T Turner
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

4.  Hypercalcaemia associated with tuberculosis.

Authors:  A G Need; P J Phillips; F Chiu; H Prisk
Journal:  Br Med J       Date:  1980-03-22

5.  An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D.

Authors:  J E Zerwekh; K Glass; J Jowsey; C Y Pak
Journal:  J Clin Endocrinol Metab       Date:  1979-08       Impact factor: 5.958

6.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3.

Authors:  L M Sandler; C G Winearls; L J Fraher; T L Clemens; R Smith; J L O'Riordan
Journal:  Q J Med       Date:  1984

8.  Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.

Authors:  J S Adams; O P Sharma; M A Gacad; F R Singer
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.

Authors:  S E Papapoulos; T L Clemens; L J Fraher; I G Lewin; L M Sandler; J L O'Riordan
Journal:  Lancet       Date:  1979-03-24       Impact factor: 79.321

10.  Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.

Authors:  P H Stern; J De Olazabal; N H Bell
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808
View more
  6 in total

Review 1.  Calcium and vitamin D metabolism in granulomatous diseases.

Authors:  M Fuss; T Pepersack; C Gillet; R Karmali; J Corvilain
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

2.  Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis.

Authors:  P F Barnes; R L Modlin; D D Bikle; J S Adams
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

3.  Dietary vitamin D affects cell-mediated hypersensitivity but not resistance to experimental pulmonary tuberculosis in guinea pigs.

Authors:  E Hernandez-Frontera; D N McMurray
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

4.  Hypercalcaemia in a child with miliary tuberculosis.

Authors:  J Gerritsen; K Knol
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

Review 5.  Calcitriol-Mediated Hypercalcemia, Somatostatin Receptors Expression and 25-Hydroxyvitamin D3-1α- Hydroxylase in GIST Tumors.

Authors:  Yiraldine Herrera-Martínez; María José Contreras González; Sergio Pedraza-Arévalo; Maria Del Carmen Guerrero Martínez; Ángela Rodrigo Martínez; Alberto González Menchen; Maria Angeles Blanco Molina; Maria Angeles Gálvez-Moreno; Alberto L Moreno-Vega; Raúl M Luque; Aura D Herrera-Martínez
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-26       Impact factor: 5.555

6.  Middle aged male with pulmonary tuberculosis and refractory hypercalcemia at a tertiary care centre in South East Asia: a case report.

Authors:  Azra Rizwan; Najmul Islam
Journal:  Cases J       Date:  2009-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.